Medical University of Vienna
🇦🇹Austria
- Country
- 🇦🇹Austria
- Ownership
- Private
- Established
- 1365-01-01
- Employees
- 1K
- Market Cap
- -
- Website
- http://www.meduniwien.ac.at
Interferon/Ribavirin-Free Sofosbuvir Based Treatment (AURIC)
Completed
- Conditions
- Chronic Hepatitis CCirrhosis
- First Posted Date
- 2015-12-11
- Last Posted Date
- 2017-09-06
- Lead Sponsor
- Medical University of Vienna
- Target Recruit Count
- 558
- Registration Number
- NCT02628717
- Locations
- 🇦🇹
Medical University of Vienna, Wien, Austria
Hepatic Venous Pressure Gradient and Platelet Activation in Chronic Liver Disease
- Conditions
- Chronic Liver Disease
- First Posted Date
- 2015-12-01
- Last Posted Date
- 2015-12-01
- Lead Sponsor
- Medical University of Vienna
- Target Recruit Count
- 100
- Registration Number
- NCT02618798
- Locations
- 🇦🇹
Department of Special Anesthesia and Pain Therapy, Medical University of Vienna, AKH Vienna, Vienna, Austria
Choroidal Thickness Vitrectomy
Completed
- Conditions
- Epiretinal Membrane
- First Posted Date
- 2015-11-30
- Last Posted Date
- 2019-10-16
- Lead Sponsor
- Medical University of Vienna
- Target Recruit Count
- 76
- Registration Number
- NCT02617147
- Locations
- 🇦🇹
Department of Ophthalmology, Medical University of Vienna, Austria, Vienna, Austria
SNPs in the DNase 1 Gene Impair Its Activity and Are Increased in a STE-ACS Patient Cohort Compared to Healthy Controls
- Conditions
- ST Elevation Myocardial Infarction
- Interventions
- Other: Blood draw
- First Posted Date
- 2015-11-25
- Last Posted Date
- 2017-03-23
- Lead Sponsor
- Medical University of Vienna
- Target Recruit Count
- 800
- Registration Number
- NCT02615015
Retromolar Route Access With and Without A Retromolar Gap
Not Applicable
Completed
- Conditions
- Airway Management
- Interventions
- Procedure: Retromolar laryngoscopy and scoring of the visualisation of the vocal cords according to Cormack & Lehane
- First Posted Date
- 2015-11-20
- Last Posted Date
- 2018-03-22
- Lead Sponsor
- Medical University of Vienna
- Target Recruit Count
- 40
- Registration Number
- NCT02611141
- Locations
- 🇦🇹
Medical University of Vienna, Vienna, Austria
Influence of Elevated Baseline Serum Creatinine and Body Composition on Acute Kidney Injury in Cardiac Surgery
Completed
- Conditions
- Acute Kidney Injury
- First Posted Date
- 2015-11-05
- Last Posted Date
- 2023-03-14
- Lead Sponsor
- Medical University of Vienna
- Target Recruit Count
- 200
- Registration Number
- NCT02598271
- Locations
- 🇦🇹
Divison of Cardiothoracic Anaesthesia and Intensive Care, Medical University of Vienna, Vienna, Austria
Histopathological Response to FOLFOXIRI + Bevacizumab in Peritoneal Metastasis From Colorectal Cancer
Phase 2
- Conditions
- Colorectal CancerPeritoneal Metastasis
- Interventions
- Procedure: Upfront staging laparoscopy + peritoneal biopsyDrug: Neoadjuvant chemotherapy with FOLFOXIRI + bevacizumabProcedure: Surgical re-exploration
- First Posted Date
- 2015-10-29
- Last Posted Date
- 2016-04-05
- Lead Sponsor
- Medical University of Vienna
- Target Recruit Count
- 30
- Registration Number
- NCT02591667
- Locations
- 🇦🇹
Medical University of Vienna, Department of Internal Medicine I, Vienna, Austria
🇦🇹Medical University of Vienna, Department of Surgery, Vienna, Austria
Endoscopic Unroofing for Small Gastric SETs
- Conditions
- Small Gastric Subepithelial Tumor
- First Posted Date
- 2015-10-27
- Last Posted Date
- 2015-10-27
- Lead Sponsor
- Medical University of Vienna
- Target Recruit Count
- 20
- Registration Number
- NCT02587923
Latanoprost Preserved Versus Unpreserved: Effect on Tear Film Thickness as Measured With OCT
Phase 4
- Conditions
- GlaucomaOcular Hypertension
- Interventions
- First Posted Date
- 2015-10-23
- Last Posted Date
- 2022-04-07
- Lead Sponsor
- Medical University of Vienna
- Target Recruit Count
- 70
- Registration Number
- NCT02585375
- Locations
- 🇦🇹
Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria
Influence of Lachrymal Substitute Gels on Tear Film Thickness in Patients With Moderate to Severe Dry Eye Syndrome
Phase 4
Completed
- Conditions
- Dry Eye Syndromes
- Interventions
- Device: Thealoz Duo GelDevice: Systane Gel DropsDevice: Hylo-Gel
- First Posted Date
- 2015-10-23
- Last Posted Date
- 2015-12-03
- Lead Sponsor
- Medical University of Vienna
- Target Recruit Count
- 60
- Registration Number
- NCT02585453
- Locations
- 🇦🇹
Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria
© Copyright 2025. All Rights Reserved by MedPath